Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study
- PMID: 29076589
- DOI: 10.1111/apm.12742
Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study
Abstract
Non-alcoholic fatty liver disease (NAFLD) is an increasingly common cause of chronic liver disease. Till date, liver biopsy remains the gold standard for identification and quantification of the wide histological spectra of NAFLD. Histological scorings are very useful and widely applied for the diagnosis and management in clinical trials and follow-up studies of non-alcoholic steatohepatitis (NASH). However, in view of scarce published literature, there is a need to evaluate them in large cohort of NAFLD. This study was aimed to evaluate the two histological scoring systems (NAS-CRN, SAF) in the diagnosis of NAFLD and to assess the role of histological characteristics as injury markers in NAFLD. Retrospective histological study of liver biopsies of 1000 patients diagnosed as NAFLD, between 2010 and 2016, was conducted. Histopathologic evaluation and semiquantiative scoring based on NAS-CRN and SAF algorithm and their correlation with serum aminotransferase and fibrosis were performed. Liver biopsies were classified according to the NAS-CRN scoring, as NAS <3 (not NASH) in 72 (7.2%), NAS 3-4 (borderline NASH) in 310 (31%), and NAS ≥5 (definite NASH) in 618 (61.8%), and SAF classified 117 (11.7%) not NASH and 883 (88.3%) definite NASH. There was excellent concordance for definite NASH and not NASH; however, 88.06% of borderline NASH was classified as NASH by SAF. 76.39% by NAS and 78.63% by SAF algorithm who were diagnosed as not NASH showed the presence of fibrosis; however, higher stages of fibrosis were significantly more prevalent in definite NASH, excluding burnt-out cirrhosis. Serum ALT was significantly associated with increasing stages of fibrosis (p < 0.001) and the three categories (not NASH, borderline NASH, and definite NASH) when classified as with/without fibrosis (p < 0.001). Steatosis of higher grades, more ballooned cells, and more foci of Lobular Inflammation were found in significantly higher proportion of patients with NASH (p < 0.001), with higher fibrosis stages (p < 0.001) and higher serum ALT levels (p < 0.001). NAFLD classifications based on histological scoring NAS-CRN and SAF algorithm are concordant for the category of definite NASH and not NASH, while borderline NASH shows discrepant interpretation. There was highly significant correlation between the NAS and SAF categories with high grades of histological characteristics, with serum ALT and with higher stages of fibrosis. Exclusion of fibrosis is a limitation with both scores.
Keywords: Non-alcoholic fatty liver disease; histology; non-alcoholic steatohepatitis; scoring.
© 2017 APMIS. Published by John Wiley & Sons Ltd.
Similar articles
-
Evaluation of NAFLD and fibrosis in obese patients - a comparison of histological and clinical scoring systems.BMC Gastroenterol. 2020 Aug 5;20(1):254. doi: 10.1186/s12876-020-01400-1. BMC Gastroenterol. 2020. PMID: 32758151 Free PMC article.
-
Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease.J Hepatol. 2020 May;72(5):828-838. doi: 10.1016/j.jhep.2019.12.008. Epub 2019 Dec 17. J Hepatol. 2020. PMID: 31862486
-
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity.Liver Int. 2019 Sep;39(9):1742-1754. doi: 10.1111/liv.14167. Epub 2019 Jun 26. Liver Int. 2019. PMID: 31169972 Free PMC article.
-
Clinical relevance of liver histopathology and different histological classifications of NASH in adults.Expert Rev Gastroenterol Hepatol. 2018 Apr;12(4):351-367. doi: 10.1080/17474124.2018.1415756. Epub 2017 Dec 26. Expert Rev Gastroenterol Hepatol. 2018. PMID: 29224471 Review.
-
Pathology of non-alcoholic fatty liver disease.Liver Int. 2017 Jan;37 Suppl 1:85-89. doi: 10.1111/liv.13301. Liver Int. 2017. PMID: 28052629 Review.
Cited by
-
Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2.J Clin Invest. 2021 Oct 15;131(20):e144801. doi: 10.1172/JCI144801. J Clin Invest. 2021. PMID: 34651580 Free PMC article.
-
Triglycerides in Nonalcoholic Fatty Liver Disease: Guilty Until Proven Innocent.Trends Pharmacol Sci. 2021 Mar;42(3):183-190. doi: 10.1016/j.tips.2020.12.001. Epub 2021 Jan 16. Trends Pharmacol Sci. 2021. PMID: 33468321 Free PMC article. Review.
-
Role of the angiopoietin-like protein family in the progression of NAFLD.Heliyon. 2024 Mar 12;10(7):e27739. doi: 10.1016/j.heliyon.2024.e27739. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38560164 Free PMC article. Review.
-
Liver Stiffness Values in Persons with Normal Histology.J Clin Exp Hepatol. 2023 Jan-Feb;13(1):10-14. doi: 10.1016/j.jceh.2022.10.008. Epub 2022 Nov 3. J Clin Exp Hepatol. 2023. PMID: 36647399 Free PMC article.
-
Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis.Biomedicines. 2021 Dec 22;10(1):15. doi: 10.3390/biomedicines10010015. Biomedicines. 2021. PMID: 35052690 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous